HARVARD BIOSCIENCE INC — Director's Dealing 2015

Aug 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-08-03

Reporting Person: Duchemin Jeffrey (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-03	Common Stock	A	71748	$0.00	Acquired	148210	Direct

Footnotes

F1: Represents a deferred stock award of 71,748 restricted stock units with performance based vesting conditions. The vesting of these restricted stock units is cliff-based and linked to the achievement of a relative total shareholder return of the Issuer's common stock from August 3, 2015 to the earlier of (i) August 3, 2018 or (ii) upon a change of control (measured relative to the Russell 3000 index and based on the 20-day trading average price before each such date). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported.

F2: Includes (a) a deferred stock award of 68,900 restricted stock units which shall vest in four equal installments on January 1, 2016, 2017, 2018 and 2019; (b) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (c) 7,562 shares of common stock held by the Reporting Person.